 
Protocol Version  8.0 – 11/5/[ADDRESS_122638] Cancer Survivors 
 
                                                                                                                                                          
Principal Investigator: [INVESTIGATOR_110297], M.D., M.P.H.    
Associate Professor , Department of Family Medi cine and Community Health  
Rutgers- Robert Wood Johnson Medical School  
Rutgers Cancer Institute of New Jersey  
[ADDRESS_122639]., Rm 452 
New Brunswick , NJ [ZIP_CODE] 
Telephone: ( 848) 932- 5252: FAX: (732) 932- 1451 
Email:  [EMAIL_2178]  
 
Subinvestigators:  
Elisa Bandera, MD, PhD   
Katie Devine, PhD    
Pamela Ohman- Strickland, PhD    
   
 
Rutgers Cancer Institute of New Jersey   Rutgers Cancer Institute of New Jersey  
Operations Center     Biostatistical Center 
Office of Human Research Services   Biometrics Division    
[ADDRESS_122640], 5th Floor 
New Brunswick, NJ 0890 3     New Brunswick, NJ 0890 3 
Telephone:  (732) 235 -8675               Telephone: (732) 235 -6791 
FAX: (732) 235 -7690     FAX: (732) 235 -7350 
 Supported by:  [CONTACT_78182] , R21CA191431  
 
ClinicalTrials.gov ID: [STUDY_ID_REMOVED]  
 
Drug(s) Under Investigation:   N/A 
__________________________  
 
 
 
 
 
 
CONFIDENTIAL  
This document is confidential and the property of the Rutgers Cancer Institute of New Jersey.  No part of it may be 
transmitted, reproduced, published, or used without prior written authorization from the study sponsor.  
  
Virtual Weight Loss Program for African -American Breast Cancer Survivors 
Jeanne Ferrante, MD, MPH  
 
Protocol Version 8.0 – 11/5/18 
 - 2 - 
  
 
 
 
TABLE OF CONTENTS  
1. PURPOSE/SPECIFIC OBJECTIVES…………………………………………………………...  4 
2. BACKGROUND AND SIGNIFICANCE………………………………………………………...  4 
3. PARTICIPATING INSTITUTIONS……………………………………………………………..  6 
4. EXPERIMENTAL DESIGN AND METHODS…………………………………………………. . 6 
4.1 DURATION OF STUDY ……………………………………………………………………………………………... 7 
5. PATIENT SELECTION CR ITERIA …………………………………………………………….  7 
5.1 INCLUSION CRITERIA ……………………………………………………………………………………………… 7 
5.2 EXCLUSION CRITERIA …………………………………………………………………………………………… ...8 
5.3 INCLUSION OF WOMEN AND MINORITIES …………………………………………………………………………. 8 
5.4 PARTICIPATION OF CHILDREN …………………………………………………………………………………….. 8 
5.5 SOURCES OR METHODS OF RECRUITMENT ……………………………………………………………………… ...8 
5.6 STUDY ENROLLMENT PROCEDURES ………………………………………………………………………………. 9 
6. STUDY PARAMETERS………………………………………………………………………….. 9 
7. DATA COLLECTION AND RECORDS TO BE KEPT ………………………………………..  10 
7.1 RESEARCH CHARTS …………………………………………………………………………………………… …..10 
7.2 REPORTS ……………………………………………………………………………………………………… ......10 
8. DATA AND SAFETY MONITORING…………………………………………………………... 10 
9. STATISTICAL CONSIDERATIONS………………………………………………………….. ..10 
9.1 PRIMARY AND SECONDARY HYPOTHESES AND ENDPOINTS ……………………………………………………… 11 
9.2 SAMPLE SIZE JUSTIFICATION …………………………………………………………………………………… ...11 
9.3 STATISTICAL ANALYSIS ………………………………………………………………………………………….. 12 
9.4 COMPLIANCE AND MISSING DATA……………………………………………………………………………… ..12 
10. HUMAN SUBJECTS……………………………………………………………………………... [ADDRESS_122641] POPULATION …………………………………………………………………………………………... 12 
10.2  POTENTIAL RISKS……………………………………………………………………………………………….. 13 
10.3  CONSENT PROCEDURES …………………………………………………………………………………………. 14 
10.4  POTENTIAL BENEFITS …………………………………………………………………………………………… 14 
10.5  RISK-BENEFIT RATIO …………………………………………………………………………………………… 14 
10.6  GENDER AND MINORITIES ………………………………………………………………………………………. 15 
11. ECONOMIC/FINANCIAL C ONSIDERATIONS ……………………………………………….. 14 
12. PUBLICATION OF RESEARCH FINDINGS …………………………………………………. .14 
13.     REFERENCES………………………………………………………………………………………[ADDRESS_122642] Cancer Survivors 
Jeanne Ferrante, MD, MPH  
 
Protocol Version 8.0 – 11/5/[ADDRESS_122643] Social Cognitive Theory  
WCHS  Women’s Circle of Health Study  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
  
Virtual Weight Loss Program for African -American Breast Cancer Survivors 
Jeanne Ferrante, MD, MPH  
 
Protocol Version 8.0 – 11/5/18 
 - 4 - 
 1. Purpose/Specific Objectives  
Our long -term goal is to help African- American (AA) breast cancer survivors maintain a healthy 
weight, thereby [CONTACT_110308] (QoL ). The 
purpose of this proposed study is to pi[INVESTIGATOR_110298] a free commercial web -based weight loss 
program  (SparkPeople ) in AA breast cancer survivors. This program is congruent with constructs of 
Social Cognitive Theory (SCT). Although this extremely popular online program has been freely 
available since 2005, there are no prospective scientific evaluations of this program, particularly 
among AA populations, who are especially in need of efficient weight control interventions.  
 1.1 Primary Objective 
Determine feasibility of using a free online commercial weight loss program (SparkPeople)  in AA 
breast cancer survivo rs, as measured by:  
1. Accrual: % patients recruited and completing baseline assessments.  
2. Study retention: % patients completing 6 month  follow -up assessment  
3. Intervention adherence and sustainability (measured at 3,6,9,12 months) : 
a. Use of website - number of log- ins, time spent, and use of features such as food 
diaries, joining teams, posting on message boards  (provided by [CONTACT_110309])  
b. Use of Fitbit monitor - % patients who wore the monitor and synced data 
c. Satisfaction (e.g., ease of use of website, usefulness of content, extra training and 
support needed) and barriers to participation (e.g., lack of computer access, lack of skills, time, interest, etc.)  
 Hypothesis: Using the online weight loss  program will be feasible in AA breast  cancer survivors 
(defined as > 75% recruitment rate and > 80% retention rate).  
 
1.[ADDRESS_122644] sizes of changes in our outcomes and potential mediators 
associated with the use of the online weight loss program. Change from baseline to 3 and 6 months in:  
1. Weight, BMI, waist circumference  (primary)  
2. Caloric intake and phys ical activity levels  
3. Cardiopulmonary fitness and cardiometabolic risk factors  (blood pressure, lipi[INVESTIGATOR_805], HbA1C) 
4. Quality of life  
5. SCT constructs (social support, self -efficacy, outcome expectations, self- regulation)  
 
2. Background and Significance  
Approximately 70% of women diagnosed with breast cancer are overweight, and many women with 
pre- and postmenopausal breast cancer gain weight after diagnosis.
1 Obesity, defined as a body 
mass index (BMI) > 30 kg/m2, is associated with later stage breast c ancer diagnosis, higher breast 
cancer recurrence and death, higher prevalence of comorbid conditions (e.g., cardiovascular disease and diabetes), and poorer health and quality of life (QoL).
2,3 The epi[INVESTIGATOR_110299] a major pubic health challenge, particularly for African -American (AA) women, who have the 
highest prevalence of obesity (at 58.6%, and expected to rise to 71% by 2020).4,[ADDRESS_122645] survival of any racial/ethnic group.[ADDRESS_122646] prevalence of diabetes, diabetes- related complications (e.g., v isual impairment and end -stage 
renal disease), hypertension, and death from diabetes and heart disease.11,[ADDRESS_122647] 
cancer diagnosis may lower  rates of recurrence,13 and it improves fitness, fatigue, and quality of life.14 
As little as 3% -5% loss of baseline weight can reduce risk of diabetes, hypertension, and 
Virtual Weight Loss Program for African -American Breast Cancer Survivors 
Jeanne Ferrante, MD, MPH  
 
Protocol Version 8.0 – 11/5/[ADDRESS_122648] cancer survivors.
1 To date, only 3 trials ([ADDRESS_122649] and 1 single -arm) have recruited significant numbers of AA 
breast cancer survivors (mean weight loss at 6 months -2.6 kg to - 5.57 kg), and all of these used 
face- to-face sessions and weekly telephone counseling.17-20 However, many patients lack access, 
financial resource s, or time to participate in face -to-face weight loss programs, and the intensive 
resources needed for this mode of delivery limit its practicality, reach and sustainability. Additionally, many patients sometimes avoid these comprehensive programs because of need for frequent face -
to-face interactions with practitioners (including dieticians) that may express weight bias (a negative 
attitude toward, belief about, or behavior against people who are overweight or obese).
21,[ADDRESS_122650] become extremely popular, due  to their 
convenience, accessibility, and social support tools. For example, SparkPeople.com, with over 13 
million hits per month, features educational and motivational articles and videos, self -monitoring tools, 
incentives, and social support communitie s (including discussion forums, teams, challenges, and 
expert blogs), with options for daily/weekly content delivered to members’ email. We chose this program , which has been freely available since 2005,  because it follows the new obesity guidelines 
that recommend a comprehensive lifestyle program including reduced calorie diet, increased physical 
activity, and behavioral strategies (e.g, self- monitoring of weight, diet, physical activity).
15 It 
emphasizes safe weight loss, including setting reasonable weight loss goals, exercising safely, and 
receiving medical attention regularly when needed. Additionally, it offers unique opportunities for 
social support (includes encouragement, motivation, informati on, and shared experiences),[ADDRESS_122651] Cancer Survivors (995 
members) and African American Newbies (7,133 members). Membe rs in SparkPeople value its 
convenience, anonymity, and non -judgmental interactions,[ADDRESS_122652] cancer survivors, who may not share personal health information to family and community members.
28 The SparkPeople program is congruent with constructs of social cognitive 
theory  (including behavioral capability  [improving knowledge and skills through articles and videos]; 
self-efficacy  [with strategies to increase confidence in one’s ability to take action including goal 
setting, self- monitoring, and reinforcements]; observational learning  [through watching videos and 
learning from others on message boards]; outcome expectations  [anticipated outcomes of 
behavior]; and reinforcement  [incentives such as  SparkPoints  are awarded for using the tools and 
features on the site]).[ADDRESS_122653] cancer, used telepho ne 
coaching and training to use SparkPeople’s self -monitoring tools.[ADDRESS_122654] 
measures of the SparkPeople website use, 64% of participants found the website helpful, and in that group, women lost mean 5.6 kg weight (SD 3.0) at 12 weeks and increased their total activity by 70 min/week (SD 40). This program use d accelerometers to collect physical activity at baseline and [ADDRESS_122655] Cancer Survivors  
Jeanne Ferrante, MD, MPH 
 
����������������� ������������ ��
 - 6 - �������������������������������������� ������������������������������������������� ��������������������
���������������������������������������� ��������������������������������������������������������������
��������������������������������������������������������������������������������������������������
����������������������������� �
�
������������������������������ �
������������������������������������� ����������������������������������� ���������������������������
����������������������������������������������������������������������������������������� �����
��������������������������������������������������������������� ������������ �������������������������
������������������������ �
�������������������������������������
�������������� ������������������������������������������� ����������������������������������������
���������������� ����������������������������������������������������������������������������������������
������������������������������������������������������������ �������������������������������������������
��������������������������������������������������������������������������������� ����������������
��������������������������������������������� �������������������������������������������������������
��������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������
��������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������
����������������� �
����������������������������������� �
�������������
�������������������������� �������������
������������������������������������
��������������������������������������������������������������������������
���������������������������������
����������������������������������������������������������������������������������������������
�����������
�������������������������
�������������������������������������
�����������������������������������
���������������������������������
�������������������������������
������������������������������������
��������������������������������
������������������������������� ���������
����������������������������������������������������������������������
����������������������������������
�������������������������Treatment 
group participants (N=35) will also receive one 30- minute session with the research assistant f or 
training on how to use the SparkPeople website (described in Significance). They may request an 
additional training session if needed. They will be  instructed to self -monitor their diet at least weekly 
(using SparkPeople) and physical activity levels da ily (using the Fitbit Force monitor, which integrates 
with SparkPeople website) .  
�

Virtual Weight Loss Program for African -American Breast Cancer Survivors 
Jeanne Ferrante, MD, MPH  
 
Protocol Version 8.0 – 11/5/[ADDRESS_122656] -based intervention includes an active phase (3 months SparkPeople plus reminders) and a 
maintenance phase (3 months SparkPeople without reminders). Because more acti ve usage of the 
website (at least weekly) is associated with greater weight loss, and low compliance and high attrition 
is a main limitation of web -based weight loss programs, treatment group subjects will receive weekly 
motivational reminders (via email, text, or phone, based on patient preference) for 3 months to log 
onto the web site, do their self- monitoring, and use the social support tools. After 3 months, subjects 
enter the maintenance phase without reminders. Follow -up meetings with the research ass istant 
during data collection meetings will also serve as reinforcements. After 6 months, control group 
participants (N~35) will receive the SparkPeople treatment, while those in the original treatment group will be followed for [ADDRESS_122657] 25 kg/m
2 will be recruited via two 
methods: (1) among participants in an on- going population- based case- control study of breast cancer 
in AA women based at Rutgers Cancer Institute of New Jersey, the Women’s Circle of Health Study 
(WCHS; Bandera, PI ; IRB protocol# 2- 2004- 5053) and (2) via distribution of study flyers at cancer 
support group  organizations and community clinics in New Jersey . Only WCHS cases agreeing to 
participate in future studies will be invited to participate in this new study and asked to signed a new informed consent specific for this protocol.  In WCHS , cases are identified through the New Jersey 
State Cancer Registry us ing rapid case ascertainment.  Cases are age [ADDRESS_122658] cancer  (Stage I -III) or ductal carcinoma in situ (DCIS  or Stage 0).  As of 
2012, there were [ADDRESS_122659] cancer cases in this study (99% Stage 0 to III), of which 221 
were obese (BMI > 30). For the community recruitment method, flyers will be mailed and emailed to 
cancer support group organizations (e.g., Sister’s Network), other community organizations (e.g., 
churches), community practices and  clinics in New Jersey , and academic or other health care 
organizations (e.g., the Cancer Institute of New Jersey, Robert Wood Johnson Medical School ,  New 
Jersey Medical School ). Flyers will be posted at these sites both physically at their location and 
digitally on their social media platforms  and/or distributed to  members/ patients to decide if they are 
interested in participating. Interested patients who see the study flyer in the community may directly 
contact [CONTACT_110310] -off portion of the flyer indicating their 
interest and contact [CONTACT_3031]. A follow -up call will be placed to these interested patients. To be 
eligible, participants must have home Internet  access or a smartphone.  While reaching 100% of the 
target population is not feas ible, the use of smart phones and home broadband connection is 
exponentially increasing in all race/ethnic groups. According to recent PEW data, 80% of African-
Americans (AAs) use the internet, and 72% of AAs have home broadband internet connection or a smartphone. Internet use is relatively high even among AAs with low education (63%) or household 
income <$30,000 (75%) .
33 
 
5.1 Inclusion Criteria 
A patient/subject is eligible for enrollment if all of the follo wing inclusion criteria are met:  
a. Patient is [ADDRESS_122660] cancer, Stage 0 (DCIS), I, 
II or III, and be at least [ADDRESS_122661] diagnosis. 
c. Patient is self -identified as African-A merican . 
d. Patient is overweight or obese (BMI > 25 kg/m2).  
Virtual Weight Loss Program for African -American Breast Cancer Survivors 
Jeanne Ferrante, MD, MPH  
 
Protocol Version 8.0 – 11/5/[ADDRESS_122662] give informed consent  for this new study . 
 
5.2 Exclusion Criteria 
A patient /subject will not be eligible for this study if any of the follo wing exclusion criteria 
are met: 
a. Patient has a s erious medical  condition (e.g., stroke, liver or renal failure, congestive heart 
failure, myocardial infarction or cardiac surgery in past year, angina pectoris) that would 
compromise the safety of the patient or compromise the patient’s ability to complete the 
study, at the discretion of the investigator.  
b. Patient has serious psychiatric condi tion (e.g., bipolar disorder, schizophrenia or other 
psychosis, bulimia or anorexia nervosa, suicide attempt within 6 months or cu rrent active 
suicidal ideation) that would compromise the patient’s ability to complete the study, at the 
discretion of the in vestigator. 
c. Patient has severe disabilities limiting moderate physical activity, such as severe 
orthopedic conditions.  
d. Patient is p lanning major surgery within the next [ADDRESS_122663] 5% of body weight in the previous [ADDRESS_122664] 3 months or planning 
pregnancy within the next 12 months.  If participant becomes pregnant during the course of 
the study, she will be removed from further participation.  
h. Patient is anticipating leaving the area within the next 12 months .   
 
5.3 Inclusion of Women and Minorities  
This study’s target population is African -American breast cancer survivors with obesity. Patient 
participants will only include women, as breast cancer occurs predominantly in women. All of the 
women will be African -American. We are targeting African -American women because they have the 
highest prevalence of obesity, breast cancer mortality, and highest rates of obesity -related 
comorbidities of any racial/ethnic group.  
5.4 Participation of Children 
Children (individuals under 21) will be excluded from the proposed research as the main research topic to be studied (obesity in breast cancer survivors) is not relevant to children.  
 
5.[ADDRESS_122665] 25 kg/m
2 will be recruited via two 
methods: (1) among participants in an on- going population- based case- control study of breast cancer 
in AA women based at Rutgers Cancer Institute of New Jersey; and (2) via distribution of study flyers 
at cancer support group organizations (e.g., Sister’s Network) , other community organizations (e.g., 
churches), community practices and clinics in New Jersey , and academic or other health care 
organizations (e.g., the Cancer Institute of New Jersey, Robert Wood Johnson Medical School,  New 
Jersey Medical School, Rutgers Cancer Institute of New Jersey at University Hospi[INVESTIGATOR_307] ). Only eligible 
women in the WCHS (Bandera, PI , IRB protocol# 2- 2004-5 053) who have expressed permission to 
be contact[CONTACT_110311] a brochure, informing them that 
they will receive a telephone call from research staff to confirm receipt of the letter and to further 
explain the study. Breast cancer survivors, who see the study flyer  in the community , may directly 
contact [CONTACT_110312] -off portion of the flyer indicating their interest and contact 
[CONTACT_110313] -American Breast Cancer Survivors 
Jeanne Ferrante, MD, MPH  
 
Protocol Version 8.0 – 11/5/18 
 - 9 - 
 information. In the proposed study, we will recruit long -term early stage survivors (Stage  0 to Stage 
III) after [ADDRESS_122666] nutritional, physical, and psychological well -being, and interfere with 
participant’s motivation and success in a weight loss intervention.  All patients who are interested and 
meet eligibility requirements will be sent a medical release form and patient informed consent form. A  
research assistant  will make a follow up call to review the forms  with the potential subjects . 
 
5.6 Study Enrollment Procedures  
A research assistant will call the potential subjects and thoroughly explain all aspects of the research 
study, assure confidentiality, and answer any patient questions. Subjects will sign the informed consent and release of medical information form for us  to obtain medical clearance from their 
physician to participate in the study. It is necessary to obtain informed consent by [CONTACT_110314] (which contains PHI) from the subjects’ physician prior to collecting any baseline data. They will mail the forms  back 
to the research team  in a pre -paid, addressed envelope. The research team will then fax the medical 
release and medical clearance form to the physician  for completion. After informed consent and 
medical clearance are obtained, the subject will meet w ith a research assistant for baseline data 
collection and measurements  (described below in Section 6). During this meeting, the research 
assistant will confirm understanding of the research study and answer any further questions. Subjects will also receive  a Fitbit physical activity monitor, trained on its use, and instructed to perform their 
usual activity over the next week to obtain their baseline activity level. After all baseline data are 
collected, the participant will be randomized to the treatment o r wait- list control group. To avoid 
selection and assignment bias, our biostatistician will develop 2 randomization schedules, one for 
each age strata, with assignment kept in separately sealed envelopes (approximately 35 subjects per 
treatment group split  within strata). After completion of the baseline assessment, the research 
associate will open  an envelope in designated order  and assign patients. Control participants will be 
told they will get an internet treatment in [ADDRESS_122667] and clinical information, and answer selected questions from the survey (Strategies used to lose weight 
and satisfaction and barriers with Fitbit and SparkPeople website.)    
 
6. Study Parameters /Measures  
In addition to demographic and clinical information, the following will be collected  at 0, 3, 6 , 9 and 12  
months  from control group participants  and at 0,3,6,12 months from  intervention group participants : 
 Outcome Measures  
• Weight (goal of at least 5% decrease within 6 months),[ADDRESS_122668] circumference - 
Anthropometric measurements  will be taken using the WCHS protocol and measuring 
instruments (measuring tape, Tanita® BF -684W scale), as described in detail elsewhere.34 
PRIMARY OUTCOME  
• Caloric intake - measured by [ADDRESS_122669] a reduced calorie diet to induce an energy deficit >500 
kcal/day.15 
• Physical activity levels - direct data downloads from the Fitbit server via the Fitabase research 
platform provide the research team an objective assessment of daily activity of participants. 
Virtual Weight Loss Program for African -American Breast Cancer Survivors 
Jeanne Ferrante, MD, MPH  
 
Protocol Version 8.0 – 11/5/[ADDRESS_122670] 150 minutes per week of moderate -high intense activity, per current 
guidelines.15, 35 
• Cardiopulmonary fitness - changes in cardiopulmonary fitness will be measured by [CONTACT_941] [ADDRESS_122671].36 
• Cardiometabolic risk factors - Blood press ure will be measured following standardized 
procedures.  Fasting serum lipi[INVESTIGATOR_805], glucose and HbA1C will be obtained through Quest 
Laboratory   (no more than 30 ml blood) 3 times during the year (at 0 , 6, 12 months). 
• Quality of life - using Quality of Life in Adult Cancer Survivors Scale, which measures physical, 
psychological, social, and spi[INVESTIGATOR_110300], and has good reliability (internal consistency ICC 
0.98), concurrent validity, and responsiveness to change in health status.37,38,39  
• Social Cognitive Theory variables - The Health Beliefs Survey measures nutrition and 
physical activity -related self -efficacy, outcome expectations, self- regulation, and social 
support. It has good reliability (cronbach’s alpha 0.72 -0.96), predictive validity, and 
sensitivity to change.40,41 
 
 
Process Measures  
• Accrual: % patients recruited and completing baseline assessments.  
• Study retention: % patients completing follow -up assessments at 6- months .  
• Intervention adherence  (at 3 and 6 months in treatment group, 9 and 12 months in control 
group) and sustainability (at 9, 12 months in treatment group) by [CONTACT_30715] : 
1. Use of website - number of log -ins to website, time spent  on site, and use of features 
such as food diaries, joini ng teams, posting on message boards (objective data provided 
by [CONTACT_110309])  
2. Use of Fitbit monitor - % patients who wore the monitor and synced data 
3. Satisfaction (e.g., ease of use of website, usefulness of content, extra training and support 
needed), barriers to participation (e.g., lack of computer access, lack of skills, time, 
interest, etc.) , and any use of internet tools or other strategies outside of intervention will 
be measured by [CONTACT_31576] -structured interviews . If control subjects use SparkPeople o n their 
own, their activity can also be monitored.  
 
7. Data Collection and Records to be Kept  
  
7.[ADDRESS_122672] been accomplished.  
 
All data will be entered or scanned into a relational database on a firewall -protected Rutgers -RWJMS 
server. Rutgers -RWJMS employs Virtual Local  Area Networks (VLAN) and Virtual Private Networks 
(VPN), in conjunction with Intrusion Detection Systems (IDS), encryption techniques and virus 
protection and detection controls.  Access to the server is only allowed for users with authorization 
and a user- specific password in order to log in the system .  The data kept on this server is in a folder 
with the Project name.  Access to this folder is restricted to the PI [INVESTIGATOR_110301].  Access 
by [CONTACT_110315]’s data folder has to be specifically authorized by [CONTACT_978] [INVESTIGATOR_110302].  All subsets of the original database that are created for analyses will be 
Virtual Weight Loss Program for African -American Breast Cancer Survivors 
Jeanne Ferrante, MD, MPH  
 
Protocol Version 8.0 – 11/5/[ADDRESS_122673] of the PI , access will be granted to the research team to 
download the dataset to his/her workstation.  These workstations are connected to the Rutgers -
RWJMS server and are password protected.  As soon as analyses are completed, the results will be 
moved to the PI’s data folder on the server and removed from the workstation.  
 
7.2 Reports 
Publications and annual reports for submission to the IRB will be written by [CONTACT_978] , co-investigator, or 
study personnel  using the data captured in the study.   
 
8. Data and Safety Monitoring 
There are no adverse events anticipated from this pi[INVESTIGATOR_110303] . 
Lifestyle interventions with diet, exercise, and behavioral therapy are already being widely used for 
behavior change among patients. The SparkPeople website is accessed by [CONTACT_46431] 13 million members monthly, and it has been shown to provide accurate information. All unexpected and/or serious 
adverse events occurring during the active portion of the intervention will be reported to the Rutgers 
CINJ Office of Human Research Services and the Rutgers IRB in accordance with IRB policy.   
 All data, including scanned copi[INVESTIGATOR_110304], will be entered into the University 
secured server described above. Data will not contain personal identifiers. The PI [INVESTIGATOR_110305]. The data safety and monitoring plan will be reviewed 
and approved by [CONTACT_110316]. 
 
9. Statistical Considerations  
9.1 Primary and Secondary Hypotheses and Endpoints  
Aim 1:  Is the intervention trial feasible?  
Hypothesis: Using the online SparkPeople program will be feasible in AA breast cancer survivors (defined as > 75% recruitment rate and > 80% retention rate).  
Other web -based obesity interventions found a recruitment rate of 50%,[ADDRESS_122674] in future studies.  
 
AIM 2 : What is the potential effect size of changes in our outcomes (at 3 and 6 months)?  
The purpose is to calculate effect sizes for a larger randomized trial, as this feasibility study is not 
powered to detect an intervention effect. However, with [ADDRESS_122675] deviations equal to those observed in Longin et al’s 2012 on -line weight loss program 
(SD=6.3 kg),
[ADDRESS_122676] 80% power to detect an effect of intervention on weight loss such that the 
intervention arm participants’ weights decrease, on average, 4.[ADDRESS_122677] participants’ weight decrease.  With respect to percent weight loss from baseline (Longin et al., SD=5.9%), we have 80% power to detect a decrease at least 4.0% more among the intervention arm.  With only [ADDRESS_122678] sizes would become 5.0 kg and 4.7%, respectively. Longin et al.’s 
one-armed trial resulted in an a verage weight loss of 5.0 kg or 4.9% from baseline among obese 
participants, similar to our detectable level with only [ADDRESS_122679] a dropout rate 
much closer to 18% (average attrition rates of other web -based lifestyle interventions),
[ADDRESS_122680] Cancer Survivors 
Jeanne Ferrante, MD, MPH  
 
Protocol Version 8.0 – 11/5/18 
 - 12 - 
 complete follow -up surveys, then we will declare the study feasible. We chose the sample size and 
decision rules so that the probability of declaring feasibility would be approximately 5% under 
unacceptable rates of acceptance and retention and exceed 95% under acceptable rates of acceptance and retention. If the true recruitment and retention rates are 57% and 60%, respectively, which we consider to be too low to warrant further research, then the probability of declaring 
feasibility would be 5%. If the true recruitment and retention rates are 75% and 80%, respectively, 
which we consider large eno ugh to warrant further research, then the probability of declaring 
feasibility would be over 95% (Table 2). The planned sample size provides sufficient power to declare 
feasibility.   
 
 
Table 2.  Probability of declaring feasibility under various assumptions  
 
Feasibility 
Component   
Unacceptable 
Rate   
Acceptable  
Rate   
Decision rule for claiming 
feasibility per outcome  Prob. Declare  
Feasible under  
Unacceptable Rates  Prob. 
Declare  
Feasible 
under  
Acceptable 
Rates  
Accrual Rate  57% 75% If [ADDRESS_122681] completed 
baseline surveys by [CONTACT_941] 107th  
(inclusive) reached  5% 99% 
Retention 
Rate  60% 80% If 50/70 participants complete 
follow -up surveys at 6 months  3% 97% 
 
9.[ADDRESS_122682] methods (percentages, means, medians) stratified by [CONTACT_30157]. In exploratory analyses, 
we will utilize mixed linear models to assess differences between treatment arms in changes in 
weight, caloric inta ke, physical activity, cardiopulmonary fitness, cardiometabolic risk factors, quality 
of life, and SCT constructs. We will also assess correlations among outcomes, examine potential 
moderators and mediators of outcomes (e.g., patient demographics, baseline  BMI, QoL, SCT 
constructs), and characterize the patterns of missing data. The percent variation explained and the 
significance of potential mediators will be examined by [CONTACT_110317].
44,[ADDRESS_122683] of the two regression coefficients governing the mediating path 
(from intervention group to mediating variable and mediating variable to outcome) will be multiplied together and compared to the overall effect of intervention group. Bootstrap procedures will be 
utilized to formally test for significance of the mediating pathway. 
 
9.4 Compliance and Missing Data 
We will measure intervention adherence (at 3 and 6 months i n treatment group, 9 and12 months in 
control group) and sustainability (at 9,12 months in treatment group) by [CONTACT_30715]:  
1. Use of website ( number of log -ins to website, time spent on site, and use of features such as 
food diaries, joining teams, posting on m essage boards (objective data provided by 
[CONTACT_110309] ); 
2. Use of Fitbit monitor (% subjects who wore the monitor and synced  data). 
3. Satisfaction (e.g., ease of use of website, usefulness of content, extra training and support 
needed), barriers to participation (e.g., lack of computer access, lack of skills, time, interest, 
etc.), and any use of internet tools or other strategies outside of intervention will be measured 
by [CONTACT_31576] -structured interviews.  
 
Weekly motivational messages will be sent and additional training with use of the SparkPeople site will be provided as needed. Information about barriers and reasons for drop out will be collected, 
making us well -positioned to comment on the support needed  to maintain adherence with a free 
Virtual Weight Loss Program for African -American Breast Cancer Survivors 
Jeanne Ferrante, MD, MPH  
 
Protocol Version 8.0 – 11/5/[ADDRESS_122684] information of participants 
(cell/home phone numbers and email addresses) as well as contact [CONTACT_110318] 3 close 
relatives/friends and p atient’s primary care doctor and oncologist will be obtained at baseline and 
verified at follow -up time points. If participants cannot complete a follow -up visit, they will be asked to 
complete the questionnaires by [CONTACT_49522]. They may also be given the option to meet at their 
physician’s office to complete the anthropometric measurements.  
 10. Human Subjects 
This human subject research meets the definition of a clinical trial, as it is a randomized controlled trial comparing an online program (SparkP eople) to a control group in decreasing weight among [ADDRESS_122685] population (N~ 70) will be recruited among participants in an on- going 
population -based case- control study of breast cancer in AA women based at Rutgers Cancer Institute 
of New Jersey, the Women’s Circle of Health Study (Bandera, PI) , or recruited from the community, 
as described above under section 5. To be eligible , participants  must be 21 -75 years old, black race, 
overweight or obese (BMI > 25), long- term early stage breast cancer survivors (Stage 0 to Stage III) 
after [ADDRESS_122686] home internet access or a 
smartphone. We will exclude individuals with serious medical (e.g., stroke, liver or renal failure, 
congestive heart failure, myocardial infarction or cardiac surgery in past year, angina pectoris) or 
psychiatric conditions (e.g., bipolar disorder, schizophrenia or other psychosis, bulimia or anorexia nervosa, suicide attempt within 6 months or current active suicidal ideation), and severe disabilities limiting moderate  physical activity and basic functional exercises, such as severe orthopedic 
conditions. Other persons excluded include: those planning major surgery, taking medications or supplements for weight loss within the past [ADDRESS_122687] 5% of body 
weight in the previous [ADDRESS_122688] 3 months or planning pregnancy within the next 2 years, or are anticipating 
leaving the area within the next 1 year.  
 All subjects will receive a handout of their goals for weight loss, diet, and physical activity based on 
current American Heart Association recommended management of obesity guidelines. Additionally all subjects will receive a Fitbit activity monitor to meas ure their activity levels. Treatment group 
participants (N=35) will receive in -person training on use of the SparkPeople website and instructed 
to self- monitor their diet (using SparkPeople) and physical activity levels, using a Fitbit monitor, which 
integ rates with the SparkPeople website. At baseline, 3, 6, 9  (control participants only)  and 12 
months, all subjects will answer questions on a survey and undergo measurements of weight, % body fat, waist circumference, cardiopulmonary fitness, and blood pressure. The intervention group 
participants will receive a phone call at [ADDRESS_122689] and clinical information, and 
answer selected questions from the survey (S trategies used to lose weight  and satisfaction and 
barriers with Fitbit and SparkPeople website.)  Additionally, blood will be collected at Quest 
Laboratories for lipi[INVESTIGATOR_805], glucose and hemoglobin A1C.  
 10.[ADDRESS_122690] articles (investigational new drugs, devices, or biologics) to be used in this study. 
Virtual Weight Loss Program for African -American Breast Cancer Survivors 
Jeanne Ferrante, MD, MPH  
 
Protocol Version 8.0 – 11/5/18 
 - 14 - 
 Lifestyle interventions with diet, exercise, and behavioral therapy are already being widely used for 
behavior change among patients. The SparkPeop le website is accessed by [CONTACT_46431] 13 million members 
monthly, and it has been shown to provide accurate information.  
 
There may be potential risks due to exertion of exercises recommended at SparkPeople. Though 
uncommon, these include such things as shortness of breath, abnormal blood pressure responses, 
fainting, nausea/vomiting, irregularities in heartbeat, or injury. The SparkPeople program emphasizes safe weight loss, including setting reasonable weight loss goals, exercising safely, and receiving 
medical  attention regularly when needed. In addition, all subjects will be given handouts with goals for 
exercise and instructed to proceed slowly and as tolerated, starting with mild -moderate exercise 10 
min/day with stepwise increase in time and intensity, as p er recommended guidelines. Any subjects 
that experience adverse events from exercise will be advised to contact [CONTACT_110319].  
There may also be skin discoloration, discomfort or soreness at the venipuncture site , which typi[INVESTIGATOR_110306] o n its own.  
 
Breach of confidentiality of participants is another potential risk. In order to ensure the protection of 
personal health information for each subject of the study, there will be no personal identifiers on any 
of the data collection instruments. Each subject will be assigned a unique subject identification 
number and this unique identifying number will serve as a link and will be secured separately. A 
master file which links the subject identification number with personal identifiers (name, dat e of birth, 
address, phone number) will be maintained separately in a password protected file on the University 
secured server.  These data will be kept only as long as specific use requires and then will be 
destroyed when all necessary linkages between data collection instruments have been accomplished. The protocol poses no other physical, psychological, financial, legal or other risk to patients.  
 
10.[ADDRESS_122691]'s physician for completion. After informed con sent and medical 
clearance are obtained, the subject will meet with a research assistant for baseline data collection 
and measurements. During this first face -to-face meeting, the research assistant will confirm 
understanding of the research study and answer any further questions. Signed, informed consent will 
be obtained before obtaining any baseline data or measurements.  
 
10.[ADDRESS_122692] Cancer Survivors 
Jeanne Ferrante, MD, MPH  
 
Protocol Version 8.0 – 11/5/18 
 - 15 - 
  10.5 Risk- Benefit Ratio 
The minimal risk involved in this study is reasonable in relation to the anticipa ted benefits of the 
research. Alternatives to participating are not participating; choosing not to participate does not affect 
patients’ medical care. Results of the proposed research will inform the feasibility and preliminary effectiveness of a free web -based program to decrease weight in AA breast cancer survivors with 
obesity. Data from this study will be used to generate sample size estimates and refine research procedures for a future R01 application that will evaluate the efficacy of the SparkPeople program in decreasing weight among AA breast cancer survivors. Results of the study may provide important 
tools to help reduce their comorbidities, improve quality and length of survival, and decrease health 
disparities. In relation to the importance of the knowledge that reasonably may be expected to result, the risks to subjects are very low.  
 
 10.[ADDRESS_122693] rates of 
obesity- related comorbidities of any racial/ethnic group.  
 
10.7 Compensation  
Participants will be provided with a free Fitbit physical activity monitor. In addition  to receiving the 
Fitbit monitoring device as incentive, all patients will receive $25 after each completed  in-person visit . 
They will also be reimbursed for parking, if needed. Additionally, participants will be rewarded with another $[ADDRESS_122694] labs.  
 
11. Economic/Financial Considerations  
This study is financed through a grant from the National Cancer Institute  R21CA191431 . 
 12. Publication of Research Findings 
The policies and procedures of the Rutgers University  legal department (see: Investigator’s 
Handbook) will govern publication of the trial.  It is expected that the results of this study  will be 
submitted for publication in a timely manner following the conclusion.  The PI [INVESTIGATOR_9627]- authors will 
review any abstract or manuscript prior to submission or use.   
Virtual Weight Loss Program for African -American Breast Cancer Survivors 
Jeanne Ferrante, MD, MPH  
 
Protocol Version 8.0 – 11/5/[ADDRESS_122695] 
cancer rehabilitation. Cancer. Apr 15 2012;118([ADDRESS_122696]):2277 -2287. 
2. Parekh N, Chandran U, Bandera EV. Obesity in cancer survival. Annu. Rev. Nutr. Aug 21 
2012;32:311- 342. 
3. Hahn KME, Bondy ML, Selvan M, et al. Factors associated with advanced disease stage at 
diagnosis in a population -based study of patients with newly diagnosed breast cancer. Am J 
Epi[INVESTIGATOR_5541]. November 1, 2007 2007;166(9):1035 -1044. 
4. Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of 
body mass index among US adults, 1999-2010. JAMA. Feb 1 2012;307(5):[ADDRESS_122697] circumference distribution shifts 
in US adults. Obesity. Jan 2009;17(1):[ADDRESS_122698] cancer at diagnosis between black and white women? J Womens Health Gend Based 
Med. 2002;11(6):527- 536. 
7. DeSantis C, Naishadham D, Jemal A. Cancer statistics for African Americans, 2013. CA Cancer J 
Clin. May 2013;63(3):[ADDRESS_122699] cancer survival in ethnically diverse postmenopausal women: the Multiethnic Cohort Study. 
Breast Cancer Res. Treat. Sep 2011;129(2):[ADDRESS_122700] cancer. J. Clin. Oncol. Sep 1 2011;29(25):[ADDRESS_122701] cancer by [CONTACT_545]/ethnicity: 
The [LOCATION_004] Breast Cancer Survivorship Consortium. Am J Epi[INVESTIGATOR_5541]. Jan 1 2014;179(1):95 -
111. 
11. Office of Minority Health, U.S. Department of Health and Human Services. Diabetes and African Americans. 2012; http://minorityhealth.hhs.gov/templates/content.aspx?lvl=3&lvlID=5&ID=3017. 
Accessed February 7, 2014.  
12. Office o f Minority Health, U.S. Department of Health and Human Services. Heart Disease and 
African Americans. 2012; http://minorityhealth.hhs.gov/templates/content.aspx?lvl=3&lvlID=6&ID=[ADDRESS_122702] cancer outcome. J Nutr. 
Jan 2007;137([ADDRESS_122703]):233S -235S.  
14. Ligibel JA, Goodwin PJ. NEW and RENEW: building the case for weight los s in breast cancer. J. 
Clin. Oncol. Jul 1 2012;30(19):2294 -2296. 
15. Jensen MD, Ryan DH, Apovian CM, et al. 2013 AHA/ACC/TOS Guideline for the Management of 
Overweight and Obesity in Adults: A Report of the American College of Cardiology/American 
Virtual Weight Loss Program for African -American Breast Cancer Survivors 
Jeanne Ferrante, MD, MPH  
 
Protocol Version 8.0 – 11/5/18 
 - 17 - 
 Heart Association Task Force on Practice Guidelines and The Obesity Society. J. Am. Coll. 
Cardiol. Nov 7 2013.  
16. Kraschnewski JL, Sciamanna CN, Stuckey HL, et al. A silent response to the obesity epi[INVESTIGATOR_901]: 
decline in US physician weight counseling. Med Care. Feb 2013;51(2):[ADDRESS_122704] cancer survivors. J Natl Med Assoc. Jun 
2009;101(6):552- 564. 
18. Greenlee HA, Crew KD, Mata JM , et al. A pi[INVESTIGATOR_110307] a commercial diet 
and exercise weight loss program in minority breast cancer survivors. Obesity (Silver Spring). Jan 
2013;21(1):[ADDRESS_122705] cancer: a systematic review. Obes Rev. Sep 2014;15(9):[ADDRESS_122706] 
cancer survivors, 2006. Prev Chronic Dis. Jan 2009;6(1):A22.  
21. Chugh M, Friedman AM, Clemow LP, Ferrante JM. Women weigh in: obese African American and 
White w omen's perspectives on physicians' roles in weight management. J Am Board Fam Med. 
Jul-Aug 2013;26(4):421 -428. PMCID: 3791510.  
22. Puhl RM, Heuer CA. Obesity stigma: important considerations for public health. Am J Public 
Health. Jun 2010;100(6):1019 -1028. 
23. Arem H, Irwin M. A review of web-based weight loss interventions in adults. Obes Rev. May 
2011;12(5):e236- 243. 
24. Aalbers T, Baars MA, Rikkert MG. Characteristics of effective Internet -mediated interventions to 
change lifestyle in people aged 50 and older: a systematic review. Ageing Res Rev. Sep 
2011;10(4):487- 497. 
25. Kodama S, Saito K, Tanaka S, et al. Effect of Web -based lifestyle modification on weight control: 
a meta -analysis. Int. J. Obes. May 2012;36(5):675 -685. 
26. Hwang KO, Ottenbacher AJ, G reen AP, et al. Social support in an Internet weight loss community. 
Int. J. Med. Inf. Jan 2010;79(1):5 -13. 
27. Wing RR, Jeffery RW. Benefits of recruiting participants with friends and increasing social support 
for weight loss and maintenance. J. Consult. Clin. Psychol. Feb 1999;67(1):[ADDRESS_122707] cancer. Psycho -Oncology. Jan 2010;19(1):62 -70. 
29. Bandura A. Social Foundations of Thought a nd Action: A Social Cognitive Theory.  Englewood 
Cliffs, NJ: Prentice -Hall; 1986.  
30. Hwang KO, Farheen K, Johnson CW, Thomas EJ, Barnes AS, Bernstam EV. Quality of weight 
loss advice on internet forums. Am J Med. Jul 2007;120(7):604 -609. 
31. Hwang KO, Ning  J, Trickey AW, Sciamanna CN. Website usage and weight loss in a free 
commercial online weight loss program: retrospective cohort study. J Med Internet Res. 
2013;15(1):e11. 
32. Cadmus -Bertram L, Wang JB, Patterson RE, Newman VA, Parker BA, Pi[INVESTIGATOR_18152]. Web -based 
self-monitoring for weight loss among overweight/obese women at increased risk for breast 
cancer: the HELP pi[INVESTIGATOR_799]. Psycho -Oncology. Aug 2013;22(8):1821 -1828. 
33. Pew Research Center. Pew Research Center's Internet & American Life Project Spring Tracking 
Survey. Home Broadband 2013. 2013; http://www.pewinternet.org/2013/08/26/home -broadband-
2013/. Accessed December 6, 2013.  
34. Bandera EV, Chandran U, Zirpoli G, et al. Body fatness and breast cancer risk in women of African ancestry. BMC Cancer. 2013;13:475.  
35. Kushi LH, Doyle C, McCullough M, et al. American Cancer Society Guidelines on nutr ition and 
physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin. Jan-Feb 2012;62(1):[ADDRESS_122708]. Respir. Care. Aug 2003;48(8):[ADDRESS_122709] Cancer Survivors 
Jeanne Ferrante, MD, MPH  
 
Protocol Version 8.0 – 11/5/18 
 - 18 - 
 37. Avis NE, Ip E, Foley KL. Evaluation of the Quality of Life in Adult Cancer Survivors (QLACS) scale 
for long- term cancer survivors in a sample of breast cancer survivors. Health Qual Life Outcomes. 
2006;4:92. 
38. Avis NE, Smith KW, McGraw S, Smith RG, Petro nis VM, Carver CS. Assessing quality of life in 
adult cancer survivors (QLACS). Qual. Life Res. May 2005;14(4):[ADDRESS_122710] cancer 
survivors. Health Qual Life Outc omes. 2012;10:14.  
40. Anderson -Bill ES, Winett RA, Wojcik JR. Social cognitive determinants of nutrition and physical 
activity among web- health users enrolling in an online intervention: the influence of social support, 
self-efficacy, outcome expectations, and self -regulation. J Med Internet Res. 2011;13(1):e28. 
41. Anderson -Bill ES, Winett RA, Wojcik JR, Winett SG. Web -based guide to health: relationship of 
theoretical variables to change in physical activity, nutrition and weight at 16 -months. J Med 
Internet Res. 2011;13(1):e27. 
42. Harvey -Berino J, West D, Krukowski R, et al. Internet delivered behavioral obesity treatment. 
Preventive Medicine. Aug 2010;51(2):[ADDRESS_122711] intervention and 
online programs. Obesity Facts. 2012;5(3):372- 383. 
44. Frazier PA, Tix AP, Barron KE. Testing moderator and mediator effects in counseling psychology research. J Couns Psychol. 2004;51(1):115 -134. 
45. Mallinckrodt B, Abraham WT, Meifen W, Russell DW. Advances in testing the statistical 
significance of medicati on effects. J Couns Psychol. 2006;53(3):372 -378. 
 
 